Literature DB >> 10855824

The pharmacology of halogenated salicylanilides and their anthelmintic use in animals.

G E Swan1.   

Abstract

The halogenated salicylanilides are a large group of compounds developed mainly for their antiparasitic activity in animals. Several halogenated salicylanilides with potent antiparasitic activity have been synthesised of which only closantel, niclosamide, oxyclozanide, rafoxanide and resorantel are commercially available. Closantel and rafoxanide, which represent the most important drugs in the group, are used extensively for the control of Haemonchus spp. and Fasciola spp. infestations in sheep and cattle and Oestrus ovis in sheep in many parts of the world. Niclosamide is used extensively for its anticestodal activity in a wide range of animals. Antiparasitic activity of the halogenated salicylanilides has also been demonstrated against a large number of other internal parasites, in particular haematophagous helminths, and external parasites including ticks and mites, in a variety of animal species. Several cases of toxicity and mortality have been reported for closantel and rafoxanide in sheep and goats. Their unique pharmacokinetic behaviour appears to play an important role in the efficacy and safety of these compounds. The chemical and physical characteristics, mode of action, pharmacokinetics, antiparasitic activity and toxicity of the halogenated salicylanilides in animals are reviewed.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10855824     DOI: 10.4102/jsava.v70i2.756

Source DB:  PubMed          Journal:  J S Afr Vet Assoc        ISSN: 1019-9128            Impact factor:   1.474


  22 in total

1.  Structure-activity studies of Wnt/β-catenin inhibition in the Niclosamide chemotype: Identification of derivatives with improved drug exposure.

Authors:  Robert A Mook; Jiangbo Wang; Xiu-Rong Ren; Minyong Chen; Ivan Spasojevic; Larry S Barak; H Kim Lyerly; Wei Chen
Journal:  Bioorg Med Chem       Date:  2015-08-10       Impact factor: 3.641

2.  Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype.

Authors:  Robert A Mook; Jiangbo Wang; Xiu-Rong Ren; Hailan Piao; H Kim Lyerly; Wei Chen
Journal:  Bioorg Med Chem Lett       Date:  2018-11-12       Impact factor: 2.823

3.  Comparative pharmacokinetics of levamisole-oxyclozanide combination in sheep and goats following per os administration.

Authors:  Cengiz Gokbulut; Hande Sultan Yalinkilinc; Dilek Aksit; Vincenzo Veneziano
Journal:  Can J Vet Res       Date:  2014-10       Impact factor: 1.310

4.  Small molecule modulators of Wnt/β-catenin signaling.

Authors:  Robert A Mook; Minyong Chen; Jiuyi Lu; Larry S Barak; H Kim Lyerly; Wei Chen
Journal:  Bioorg Med Chem Lett       Date:  2013-01-30       Impact factor: 2.823

5.  The ionophore oxyclozanide enhances tobramycin killing of Pseudomonas aeruginosa biofilms by permeabilizing cells and depolarizing the membrane potential.

Authors:  Michael M Maiden; Mitchell P Zachos; Christopher M Waters
Journal:  J Antimicrob Chemother       Date:  2019-04-01       Impact factor: 5.758

6.  Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus.

Authors:  Rajmohan Rajamuthiah; Beth Burgwyn Fuchs; Annie L Conery; Wooseong Kim; Elamparithi Jayamani; Bumsup Kwon; Frederick M Ausubel; Eleftherios Mylonakis
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

7.  Reprofiled anthelmintics abate hypervirulent stationary-phase Clostridium difficile.

Authors:  Major Gooyit; Kim D Janda
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

8.  A phenotypic small-molecule screen identifies halogenated salicylanilides as inhibitors of fungal morphogenesis, biofilm formation and host cell invasion.

Authors:  Carlos Garcia; Anaïs Burgain; Julien Chaillot; Émilie Pic; Inès Khemiri; Adnane Sellam
Journal:  Sci Rep       Date:  2018-08-01       Impact factor: 4.379

Review 9.  Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi.

Authors:  Lucie Peyclit; Hanane Yousfi; Jean-Marc Rolain; Fadi Bittar
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-20

10.  Niclosamide ethanolamine-induced mild mitochondrial uncoupling improves diabetic symptoms in mice.

Authors:  Hanlin Tao; Yong Zhang; Xiangang Zeng; Gerald I Shulman; Shengkan Jin
Journal:  Nat Med       Date:  2014-10-05       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.